Cellcom Israel (NYSE:CEL) was downgraded by Zacks from an “outperform” rating to a “neutral” rating in a research report issued on Thursday, StockRatingsNetwork.com reports. They currently have a $11.70 target price on the stock. Zacks‘ price target indicates a potential upside of 5.41% from the company’s current price.
Shares of Cellcom Israel (NYSE: CEL) traded up 0.27% during mid-day trading on Thursday, hitting $11.10. Cellcom Israel has a 52 week low of $5.32 and a 52 week high of $11.18. The stock’s 50-day moving average is currently $9.5. The company has a market cap of $1.110 billion and a P/E ratio of 9.99.
Cellcom Israel (NYSE:CEL) last posted its quarterly earnings results on Monday, May 13th. The company reported $0.67 earnings per share for the quarter, missing the analysts’ consensus estimate of $1.23 by $0.56. The company had revenue of $1.26 billion for the quarter, compared to the consensus estimate of $1.43 billion. During the same quarter in the previous year, the company posted $1.74 earnings per share. The company’s revenue for the quarter was down 20.6% on a year-over-year basis. On average, analysts predict that Cellcom Israel will post $3.00 earnings per share for the current fiscal year.
Cellcom Israel Ltd. (NYSE: CEL) is a provider of cellular communications services in Israel.
To view Zacks’ full report, visit www.zacks.com